S&P 500 7,459.94 â–ŧ 73.83 (-0.98%) DOW 52,169.10 â–ŧ 383.87 (-0.73%) NASDAQ 25,535.42 â–ŧ 346.53 (-1.34%) US Markets Closed â€ĸ 08:12 AM ET

PRPO

Precipio, Inc.

Price Chart
Latest Quote

$24.64

+0.96 (+4.05%)
Current Price
Previous Close $23.68
Open $23.68
Day High $24.64
Day Low $23.10
Volume 108,317
Fetched: 2026-07-18T12:12:38
Stock Information
Shares Outstanding 1.79M
Total Debt $3.49M
Cash Equivalents $2.60M
Revenue $25.83M
Net Income $-922K
Sector Healthcare
Industry Diagnostics & Research
Market Cap $44.04M
EPS (TTM) $-0.45
Exchange NCM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$44.93M
Sales$25.83M
Income$-922K
Book/sh$7.94
Cash/sh$1.46
Employees61
Financial Ratios
Quick Ratio1.21
Current Ratio1.56
Debt/Eq24.65
Returns & Margins
ROA-5.74%
ROE-7.13%
Gross Margin43.71%
Operating Margin-21.28%
Profit Margin-3.57%
Ownership
Insider Ownership12.59%
Institutional Ownership17.66%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E63.18
P/S1.70
P/B3.10
Analyst Data
Recommendationnone
Technical Indicators
SMA20$24.26
SMA50$24.56
SMA200$24.18
RSI55.83
ATR2.3179
Shares Float1.40M
Short Float1.69%
Short Ratio0.86
Volatility1.28
Rel Volume1.54
Performance History
Week+3.53%
Month+10.72%
Quarter-15.03%
6 Months+2.67%
YTD+3.44%
Year+68.42%
3 Years+256.07%
5 Years-64.29%
10 Years-99.09%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-07-17 $24.64 108,300
2026-07-16 $23.68 193,600
2026-07-15 $25.24 170,500
2026-07-14 $23.20 100,800
2026-07-13 $24.00 121,300
2026-07-10 $23.80 143,300
2026-07-09 $26.48 152,100
2026-07-08 $26.12 45,600
2026-07-07 $26.00 33,800
2026-07-06 $25.26 62,600
2026-07-02 $25.26 6,900
2026-07-01 $24.93 12,700
2026-06-30 $24.76 16,200
2026-06-29 $24.28 5,300
2026-06-26 $23.31 54,300
2026-06-25 $22.41 18,400
2026-06-24 $22.96 26,400
2026-06-23 $23.20 74,300
2026-06-22 $23.25 17,000
2026-06-18 $22.45 38,800
About Precipio, Inc.

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $13,343,000 $10,973,000 $9,179,000 $6,902,000
Cost Of Revenue $13,343,000 $10,973,000 $9,179,000 $6,902,000
Total Revenue $24,049,000 $18,532,000 $15,197,000 $9,412,000
Operating Revenue $24,246,000 $18,576,000 $15,415,000 $8,418,000
Expenses
Interest Expense $73,000 $74,000 $18,000 $12,000
Total Expenses $25,251,000 $22,748,000 $22,817,000 $22,209,000
Other Income Expense $912,000 - $1,785,000 $631,000
Other Non Operating Income Expenses $123,000 - $65,000 $25,000
Net Non Operating Interest Income Expense $-73,000 $-74,000 $-18,000 $-12,000
Interest Expense Non Operating $73,000 $74,000 $18,000 $12,000
Operating Expense $11,908,000 $11,775,000 $13,638,000 $15,307,000
Other Operating Expenses $11,908,000 $11,775,000 $13,638,000 $15,307,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-363,000 $-4,290,000 $-5,853,000 $-12,203,000
Net Interest Income $-73,000 $-74,000 $-18,000 $-12,000
Normalized Income $-1,152,000 $-4,290,000 $-7,573,000 $-12,834,000
Net Income From Continuing And Discontinued Operation $-363,000 $-4,290,000 $-5,853,000 $-12,203,000
Total Operating Income As Reported $-1,202,000 $-4,216,000 $-7,620,000 $-12,797,000
Net Income Common Stockholders $-363,000 $-4,290,000 $-5,853,000 $-12,203,000
Net Income $-363,000 $-4,290,000 $-5,853,000 $-12,203,000
Net Income Including Noncontrolling Interests $-363,000 $-4,290,000 $-5,853,000 $-12,178,000
Net Income Continuous Operations $-363,000 $-4,290,000 $-5,853,000 $-12,178,000
Pretax Income $-363,000 $-4,290,000 $-5,853,000 $-12,178,000
Special Income Charges $789,000 $0 $1,720,000 $25,000
Operating Income $-1,202,000 $-4,216,000 $-7,620,000 $-12,797,000
Gross Profit $10,706,000 $7,559,000 $6,018,000 $2,510,000
Per Share
Diluted EPS $-0.23 $-2.93 $-4.51 $-10.73
Basic EPS $-0.23 $-2.93 $-4.51 $-10.73
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $673,000 $-2,703,000 $-6,038,000 $-11,277,000
Total Unusual Items $789,000 $0 $1,720,000 $631,000
Total Unusual Items Excluding Goodwill $789,000 $0 $1,720,000 $631,000
Reconciled Depreciation $1,752,000 $1,513,000 $1,517,000 $1,520,000
EBITDA (Bullshit earnings) $1,462,000 $-2,703,000 $-4,318,000 $-10,646,000
EBIT $-290,000 $-4,216,000 $-5,835,000 $-12,166,000
Diluted Average Shares $1,605,080 $1,465,518 $1,297,851 $1,137,573
Basic Average Shares $1,605,080 $1,465,518 $1,297,851 $1,137,573
Diluted NI Availto Com Stockholders $-363,000 $-4,290,000 $-5,853,000 $-12,203,000
Tax Provision $0 $0 $0 $0
Other Special Charges $-789,000 - $-1,720,000 $-25,000
Minority Interests - - $0 $-25,000
Gain On Sale Of Security - - - $606,000
Fetched: 2026-07-15
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $3,642,000 $225,000 $1,611,000 $2,534,000
Total Assets $21,317,000 $16,996,000 $18,101,000 $21,504,000
Total Non Current Assets $15,278,000 $13,545,000 $14,419,000 $15,794,000
Other Non Current Assets $67,000 $45,000 $76,000 $129,000
Goodwill And Other Intangible Assets $10,919,000 $11,869,000 $12,818,000 $13,768,000
Other Intangible Assets $10,919,000 $11,869,000 $12,818,000 $13,768,000
Current Assets $6,039,000 $3,451,000 $3,682,000 $5,710,000
Other Current Assets $469,000 $539,000 $495,000 $521,000
Inventory $935,000 $724,000 $384,000 $708,000
Receivables $1,984,000 $799,000 $1,301,000 $1,036,000
Accounts Receivable $1,984,000 $799,000 $1,301,000 $1,036,000
Allowance For Doubtful Accounts Receivable $-1,045,000 $-995,000 $-2,572,000 $-2,354,000
Gross Accounts Receivable $3,029,000 $1,794,000 $3,873,000 $3,390,000
Cash Cash Equivalents And Short Term Investments $2,651,000 $1,389,000 $1,502,000 $3,445,000
Cash And Cash Equivalents $2,651,000 $1,389,000 $1,502,000 $3,445,000
Cash Financial $2,651,000 $1,389,000 $1,502,000 $3,445,000
Debt
Total Debt $3,653,000 $1,253,000 $1,116,000 $1,392,000
Long Term Debt And Capital Lease Obligation $3,004,000 $631,000 $531,000 $776,000
Long Term Debt $47,000 $77,000 $106,000 $134,000
Current Debt And Capital Lease Obligation $649,000 $622,000 $585,000 $616,000
Current Debt $30,000 $297,000 $235,000 $255,000
Other Current Borrowings $30,000 $297,000 $235,000 $255,000
Liabilities
Total Liabilities Net Minority Interest $6,756,000 $4,902,000 $3,672,000 $5,137,000
Total Non Current Liabilities Net Minority Interest $3,004,000 $631,000 $531,000 $776,000
Current Liabilities $3,752,000 $4,271,000 $3,141,000 $4,361,000
Current Deferred Liabilities $282,000 $232,000 $110,000 $119,000
Payables And Accrued Expenses $1,844,000 $2,462,000 $1,692,000 $3,135,000
Interest Payable $19,000 $19,000 $19,000 $19,000
Payables $1,340,000 $791,000 $909,000 $2,133,000
Total Tax Payable $209,000 $173,000 $287,000 $91,000
Accounts Payable $1,131,000 $618,000 $622,000 $2,042,000
Derivative Product Liabilities - - - $0
Equity
Common Stock Equity $14,561,000 $12,094,000 $14,429,000 $16,302,000
Total Equity Gross Minority Interest $14,561,000 $12,094,000 $14,429,000 $16,367,000
Stockholders Equity $14,561,000 $12,094,000 $14,429,000 $16,302,000
Retained Earnings $-102,803,000 $-102,440,000 $-98,150,000 $-92,297,000
Other
Preferred Shares Number $2,586,205 $2,586,205 $2,586,205 $2,586,205
Ordinary Shares Number $1,780,899 $1,493,639 $1,420,125 $1,141,013
Share Issued $1,780,899 $1,493,639 $1,420,125 $1,141,013
Tangible Book Value $3,642,000 $225,000 $1,611,000 $2,534,000
Invested Capital $14,638,000 $12,468,000 $14,770,000 $16,691,000
Working Capital $2,287,000 $-820,000 $541,000 $1,349,000
Capital Lease Obligations $3,576,000 $879,000 $775,000 $1,003,000
Total Capitalization $14,608,000 $12,171,000 $14,535,000 $16,436,000
Additional Paid In Capital $117,346,000 $114,519,000 $112,565,000 $108,588,000
Capital Stock $18,000 $15,000 $14,000 $11,000
Common Stock $18,000 $15,000 $14,000 $11,000
Preferred Stock $0 $0 $0 $0
Long Term Capital Lease Obligation $2,957,000 $554,000 $425,000 $642,000
Current Deferred Revenue $282,000 $232,000 $110,000 $119,000
Current Capital Lease Obligation $619,000 $325,000 $350,000 $361,000
Pensionand Other Post Retirement Benefit Plans Current $977,000 $955,000 $754,000 $491,000
Current Accrued Expenses $504,000 $1,671,000 $783,000 $1,002,000
Net PPE $4,292,000 $1,631,000 $1,525,000 $1,897,000
Accumulated Depreciation $-1,866,000 $-1,627,000 $-1,377,000 $-1,102,000
Gross PPE $6,158,000 $3,258,000 $2,902,000 $2,999,000
Construction In Progress $27,000 $86,000 $30,000 $34,000
Other Properties $4,796,000 $1,929,000 $1,751,000 $1,951,000
Machinery Furniture Equipment $1,335,000 $1,243,000 $1,121,000 $1,014,000
Minority Interest - $0 $0 $65,000
Fetched: 2026-07-15
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $359,000 $216,000 $-3,685,000 $-7,998,000
Operating Activities
Operating Cash Flow $685,000 $439,000 $-3,559,000 $-7,721,000
Cash Flow From Continuing Operating Activities $685,000 $439,000 $-3,559,000 $-7,721,000
Operating Gains Losses $20,000 - $-65,000 $-606,000
Investing Activities
Capital Expenditure $-326,000 $-223,000 $-126,000 $-277,000
Investing Cash Flow $-326,000 $-223,000 $-126,000 $-277,000
Cash Flow From Continuing Investing Activities $-326,000 $-223,000 $-126,000 $-277,000
Financing Activities
Issuance Of Capital Stock $0 $78,000 $2,245,000 $129,000
Financing Cash Flow $903,000 $-329,000 $1,742,000 $-225,000
Cash Flow From Continuing Financing Activities $903,000 $-329,000 $1,742,000 $-225,000
Net Common Stock Issuance $0 $78,000 $2,245,000 $129,000
Common Stock Issuance $0 $78,000 $2,245,000 $129,000
Net Other Financing Charges - - - -
Other
Repayment Of Debt $-477,000 $-657,000 $-503,000 $-365,000
Issuance Of Debt $0 $250,000 $0 -
Interest Paid Supplemental Data $100,000 $85,000 $42,000 $45,000
End Cash Position $2,651,000 $1,389,000 $1,502,000 $3,445,000
Beginning Cash Position $1,389,000 $1,502,000 $3,445,000 $11,668,000
Changes In Cash $1,262,000 $-113,000 $-1,943,000 $-8,223,000
Proceeds From Stock Option Exercised $1,380,000 $0 $0 $11,000
Net Issuance Payments Of Debt $-477,000 $-407,000 $-503,000 $-365,000
Net Long Term Debt Issuance $-477,000 $-407,000 $-503,000 $-365,000
Long Term Debt Payments $-477,000 $-657,000 $-503,000 $-365,000
Long Term Debt Issuance $0 $250,000 $0 -
Net PPE Purchase And Sale $-326,000 $-223,000 $-126,000 $-277,000
Purchase Of PPE $-326,000 $-223,000 $-126,000 $-277,000
Change In Working Capital $-2,169,000 $1,270,000 $606,000 $-643,000
Change In Other Working Capital $50,000 $122,000 $-9,000 $101,000
Change In Other Current Liabilities $-241,000 $-218,000 $-206,000 $-182,000
Change In Other Current Assets $48,000 $303,000 $451,000 $491,000
Change In Payables And Accrued Expense $-453,000 $965,000 $529,000 $-164,000
Change In Accrued Expense $-966,000 $975,000 $698,000 $-329,000
Change In Payable $513,000 $-10,000 $-169,000 $165,000
Change In Account Payable $513,000 $-10,000 $-169,000 $165,000
Change In Inventory $-211,000 $-340,000 $324,000 $-144,000
Change In Receivables $-1,362,000 $438,000 $-483,000 $-745,000
Changes In Account Receivables $-1,362,000 $438,000 $-483,000 $-745,000
Other Non Cash Items $-182,000 $5,000 $-1,717,000 $-21,000
Stock Based Compensation $1,450,000 $1,877,000 $1,735,000 $3,801,000
Provisionand Write Offof Assets $177,000 $64,000 $218,000 $406,000
Depreciation Amortization Depletion $1,752,000 $1,513,000 $1,517,000 $1,520,000
Depreciation And Amortization $1,752,000 $1,513,000 $1,517,000 $1,520,000
Depreciation $1,752,000 $1,513,000 $1,517,000 $1,520,000
Net Income From Continuing Operations $-363,000 $-4,290,000 $-5,853,000 $-12,178,000
Gain Loss On Sale Of Business - $0 $-65,000 $0
Gain Loss On Investment Securities - - - $-606,000
Sale Of PPE - - - -
Gain Loss On Sale Of PPE - - - -
Fetched: 2026-07-15